[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd)

[Kirsten Myhr <myhr@online.no>]

E-drug: Doxycycline becomes D.C.'s anthrax drug (cont'd)
-------------------------------------------------------------------------

Jamie,

I think we have already given you the information that is available
through links to reports (JAMA, WHO) that discuss options. Today
the CDC has also released treatment guidelines.
http://www.cdc.gov/mmwr/PDF/wk/mm5042.pdf

There is also an article in the Journal of The American
Health-Systems Pharmacists:
Terriff CM, Tee AM. Citywide preparation for bioterrorism. Am J
Health-Syst Pharm 2001; 58: 233-7.

The issue of antibacterial resistance is not a straightforward one
and should be dealt with by microbiologists. I think that CDC, being
a WHO Collaborating Centre, should address that issue.

Kirsten

Kirsten Myhr
Head of Eastern Health Region Drug Information Centre

RELIS Ost
Ulleval University Hospital
0407 Oslo, Norway
Tel.: +47 23 01 64 11(o)   Fax: +47 23 01 64 10
+47 22 56 05 85 (h)   mobile: +47 416 38 747
myhr@online.no (h)
kirsten.myhr@relis.ulleval.no (w)
www.relis.no


--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://satellife.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.